A genome-wide association study yields five novel thyroid cancer risk loci

The great majority of thyroid cancers are of the non-medullary type. Here we report findings from a genome-wide association study of non-medullary thyroid cancer, including in total 3,001 patients and 287,550 controls from five study groups of European descent. Our results yield five novel loci (all with Pcombined<3 × 10−8): 1q42.2 (rs12129938 in PCNXL2), 3q26.2 (rs6793295 a missense mutation in LRCC34 near TERC), 5q22.1 (rs73227498 between NREP and EPB41L4A), 10q24.33 (rs7902587 near OBFC1), and two independently associated variants at 15q22.33 (rs2289261 and rs56062135; both in SMAD3). We also confirm recently published association results from a Chinese study of a variant on 5p15.33 (rs2736100 near the TERT gene) and present a stronger association result for a moderately correlated variant (rs10069690; OR=1.20, P=3.2 × 10−7) based on our study of individuals of European ancestry. In combination, these results raise several opportunities for future studies of the pathogenesis of thyroid cancer.

[1]  M H Skolnick,et al.  Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. , 1994, Journal of the National Cancer Institute.

[2]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[3]  William Wheeler,et al.  Genome-wide association study identifies multiple loci associated with bladder cancer risk. , 2014, Human molecular genetics.

[4]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[5]  Barbara Jarzab,et al.  Genome-wide association study on differentiated thyroid cancer. , 2013, The Journal of clinical endocrinology and metabolism.

[6]  K. Czene,et al.  Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family‐cancer database , 2002, International journal of cancer.

[7]  Lisa Helbling Chadwick,et al.  The NIH Roadmap Epigenomics Program data resource. , 2012, Epigenomics.

[8]  E. Lukhtanov,et al.  A novel endonuclease IV post-PCR genotyping system , 2006, Nucleic acids research.

[9]  Brent S. Pedersen,et al.  Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis , 2013, Nature Genetics.

[10]  Pall I. Olason,et al.  Detection of sharing by descent, long-range phasing and haplotype imputation , 2008, Nature Genetics.

[11]  M. Pelizzo,et al.  The Variant rs1867277 in FOXE1 Gene Confers Thyroid Cancer Susceptibility through the Recruitment of USF1/USF2 Transcription Factors , 2009, PLoS genetics.

[12]  T. Spector,et al.  Common variants near TERC are associated with mean telomere length , 2010, Nature Genetics.

[13]  Anders Albrechtsen,et al.  Weighting sequence variants based on their annotation increases power of whole-genome association studies , 2016, Nature Genetics.

[14]  Kari Stefansson,et al.  Discovery of common variants associated with low TSH levels and thyroid cancer risk , 2012, Nature Genetics.

[15]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[16]  D. Chasman,et al.  Genome-Wide Association Study of Relative Telomere Length , 2011, PloS one.

[17]  R. DeLellis.  Pathology and genetics of thyroid carcinoma , 2006, Journal of surgical oncology.

[18]  Wei Lu,et al.  Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer , 2013, Nature Genetics.

[19]  Bjarni V. Halldórsson,et al.  Large-scale whole-genome sequencing of the Icelandic population , 2015, Nature Genetics.

[20]  Marko Hočevar,et al.  Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma , 2015, Nature Genetics.

[21]  F. Ishikawa,et al.  RPA-like mammalian Ctc1-Stn1-Ten1 complex binds to single-stranded DNA and protects telomeres independently of the Pot1 pathway. , 2009, Molecular cell.

[22]  I. Ial,et al.  Nature Communications , 2010, Nature Cell Biology.

[23]  W. Engel,et al.  Lrrc34, a novel nucleolar protein, interacts with npm1 and ncl and has an impact on pluripotent stem cells. , 2014, Stem cells and development.

[24]  P. Guénel,et al.  Fine‐mapping of two differentiated thyroid carcinoma susceptibility loci at 9q22.33 and 14q13.3 detects novel candidate functional SNPs in Europeans from metropolitan France and Melanesians from New Caledonia , 2016, International journal of cancer.

[25]  Wei Li,et al.  Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters. , 2016, Thyroid : official journal of the American Thyroid Association.

[26]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[27]  Data production leads,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[28]  K. Pollard,et al.  Enhancer–promoter interactions are encoded by complex genomic signatures on looping chromatin , 2016, Nature Genetics.

[29]  Boris Lenhard,et al.  Patterns of regulatory activity across diverse human cell types predict tissue identity, transcription factor binding, and long-range interactions , 2013, Genome research.

[30]  M. Peters,et al.  Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.

[31]  Thomas W. Mühleisen,et al.  Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk , 2013, Nature Genetics.

[32]  K. Hemminki,et al.  A Comprehensive Meta-analysis of Case–Control Association Studies to Evaluate Polymorphisms Associated with the Risk of Differentiated Thyroid Carcinoma , 2016, Cancer Epidemiology, Biomarkers & Prevention.

[33]  Kari Stefansson,et al.  Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations , 2009, Nature Genetics.

[34]  K. Hemminki,et al.  Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk. , 2014, The Journal of clinical endocrinology and metabolism.

[35]  ENCODEConsortium,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[36]  G. Boss,et al.  A DNA Polymerase-α·Primase Cofactor with Homology to Replication Protein A-32 Regulates DNA Replication in Mammalian Cells* , 2009, Journal of Biological Chemistry.

[37]  P. Donnelly,et al.  A new multipoint method for genome-wide association studies by imputation of genotypes , 2007, Nature Genetics.

[38]  K. Hemminki,et al.  Novel genetic variants in differentiated thyroid cancer and assessment of the cumulative risk , 2015, Scientific Reports.

[39]  Shicheng Guo,et al.  Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population , 2013, Journal of Medical Genetics.

[40]  L. Kiemeney,et al.  Cohort Profile Cohort Profile : The Nijmegen Biomedical Study ( NBS ) , 2017 .

[41]  S. Heath,et al.  The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. , 2010, Human molecular genetics.

[42]  Pieter B. T. Neerincx,et al.  Supplementary Information Whole-genome sequence variation , population structure and demographic history of the Dutch population , 2022 .

[43]  P. O’Reilly,et al.  Identification of seven loci affecting mean telomere length and their association with disease , 2013, Nature Genetics.

[44]  S. Asa,et al.  Pathogenetic mechanisms in thyroid follicular-cell neoplasia , 2006, Nature Reviews Cancer.

[45]  D. Gudbjartsson,et al.  Cancer as a Complex Phenotype: Pattern of Cancer Distribution within and beyond the Nuclear Family , 2004, PLoS medicine.

[46]  Andrew D. Johnson,et al.  Genome-wide association identifies OBFC1 as a locus involved in human leukocyte telomere biology , 2010, Proceedings of the National Academy of Sciences.

[47]  A. Gylfason,et al.  Fine-scale recombination rate differences between sexes, populations and individuals , 2010, Nature.

[48]  Giuseppe Opocher,et al.  Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations , 2015, International journal of cancer.

[49]  Daniel Rios,et al.  Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor , 2022 .

[50]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[51]  David H. Alexander,et al.  Fast model-based estimation of ancestry in unrelated individuals. , 2009, Genome research.

[52]  Raymond K. Auerbach,et al.  A User's Guide to the Encyclopedia of DNA Elements (ENCODE) , 2011, PLoS biology.

[53]  Peter Kraft,et al.  Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression , 2013, Human molecular genetics.

[54]  Jean-François Zagury,et al.  Haplotype estimation using sequencing reads. , 2013, American journal of human genetics.

[55]  Z. Du,et al.  Functional evaluation of TERT-CLPTM1L genetic variants associated with susceptibility of papillary thyroid carcinoma , 2016, Scientific Reports.

[56]  Huiling He,et al.  Genetic predisposition to papillary thyroid carcinoma: involvement of FOXE1, TSHR, and a novel lincRNA gene, PTCSC2. , 2015, The Journal of clinical endocrinology and metabolism.

[57]  Kári Stefánsson,et al.  Protection of privacy by third-party encryption in genetic research in Iceland , 2000, European Journal of Human Genetics.

[58]  D. Gudbjartsson,et al.  Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma , 2015, Nature Communications.

[59]  Sandya Liyanarachchi,et al.  Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer , 2015, Proceedings of the National Academy of Sciences.

[60]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.